cart

Documents about cart

• One horse cart#941914NYU Faculty Digital Archive
• Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART#910260ClinicalTrials.gov
• Optimal LQR Controller Methods for Double Inverted Pendulum System on a Cart#364438Muş Alparslan University Institutional Repository
• CD19-CART Treatment for ALL#835117ClinicalTrials.gov
• Combination Antiretroviral Therapy (cART) for PBC#893213ClinicalTrials.gov
• CART-19 Cells For R/R B-ALL#201756ClinicalTrials.gov
• CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)#827526ClinicalTrials.gov
• Flower Cart in a Courtyard in Sedona, AZ#424142Bryant Digital Repository
• Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies#894669ClinicalTrials.gov
• On Stopping Rules and Spatial Adaptation for CART#616299arXiv (OAI Expanded)
• On Stopping Rules and Spatial Adaptation for CART#616799arXiv (All)
• Green Cart Program Evaluation#892647ClinicalTrials.gov
• Interaction Between HIV and Platelets#908564ClinicalTrials.gov
• Effects of Intensive cART During Acute/Early HIV Infection#911592ClinicalTrials.gov
• Determining Expression Levels of the Notch Signaling Pathway in Self-Renewing hASCs#939383Louisiana Tech Digital Commons
• PD1-CD19-CART in Patients With r/r B-cell Lymphoma#994259ClinicalTrials.gov
• Cardiovascular Effects of CART Cell Therapy#300244ClinicalTrials.gov
• Garbage collection circa 1910#941913NYU Faculty Digital Archive
• CAR-T Cell Therapy in Patients With Hematological Malignancies#837549ClinicalTrials.gov
• The Little Clay Cart [Mṛcchakaṭika]#40658Project Gutenberg
• #ADD-TO-CART: APPLIED FINANCIAL LITERACY AND ONLINE PURCHASE DECISION-MAKING OF GRADE 12 STUDENTS#72685PhilArchive
• LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer#895456ClinicalTrials.gov
• Street Sweeping circa 1910#941910NYU Faculty Digital Archive
• An Investigation of Missing Data Methods for Classification Trees#942812NYU Faculty Digital Archive
• B7-H3.CD28Z.CART in Solid Tumors#992016ClinicalTrials.gov
• Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma#349953ClinicalTrials.gov
• CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma#377403ClinicalTrials.gov
• The Role of Notch Signaling and Environmental Factors in Adult Stem Cell Myogenic and Osteogenic Differentiation#958492Louisiana Tech Digital Commons
• The Spectre In The Cart 1908#42043Project Gutenberg
• Revamping molecular biology for the twentieth first century, or putting back the theoretical horse ahead of the technological cart#117200PhilArchive
• Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation#454026ClinicalTrials.gov
• Evaluation of Third-line cART Regimen in Cambodia (3DICAM)#850261ClinicalTrials.gov
• CDS approximation accuracy improvement with CART and random forest algorithms based on a time span including the COVID-19 pandemic period#283845DORAS
• CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia#373599ClinicalTrials.gov
• Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)#802320ClinicalTrials.gov
• The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer#864961ClinicalTrials.gov
• Annual Report 1936, D.S. Progress#941873NYU Faculty Digital Archive
• Putting the Cart Before the Horse: Trait Disgust Propensity Cannot Mediate Immediate Stimulus Responses#302258OSF
• A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors#909452ClinicalTrials.gov
• Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL#902109ClinicalTrials.gov
• Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma#908922ClinicalTrials.gov
• The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia#857896ClinicalTrials.gov
• A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities#900174ClinicalTrials.gov
• CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH#343840ClinicalTrials.gov
• Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction#837598ClinicalTrials.gov
• A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007#840320ClinicalTrials.gov
• Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever#429771ClinicalTrials.gov
• CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）#854628ClinicalTrials.gov
• Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis#889831ClinicalTrials.gov
• CART-19 for Multiple Myeloma#896745ClinicalTrials.gov